CA
IMUX icon

Cliff Asness’s Immunic IMUX Stock Holding History

Cliff Asness’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-153
Closed -$12K – 2127
2019
Q1 		$12K Sell
153
-1,336
-90% -$117K ﹤0.01% 2158
2018
Q4 		$111K Buy
1,489
+1,369
+1,141% +$160K ﹤0.01% 2142
2018
Q3 		$13K Buy
120
+31
+35% +$80.9K ﹤0.01% 2254
2018
Q2 		$244K Buy
+89
New +$206K ﹤0.01% 2175

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cliff Asness's IMUX Position: Q2 2019 in Review

Cliff Asness sold out of Immunic (IMUX) in Q2 2019, closing a stake of 153 shares — an estimated $12K sold.

Cliff Asness first reported a position in IMUX in Q2 2018 and held it in 4 quarters. The position peaked at $244K in Q2 2018. 24 funds tracked by Wall St. Rank hold IMUX as of Q2 2019.

  • Cliff Asness reported no remaining Immunic position as of Q2 2019 after selling out during the quarter.
  • Cliff Asness sold 153 Immunic shares in Q2 2019, an estimated $12K.
  • Cliff Asness first reported a position in Immunic in Q2 2018 and held it in 4 quarters.
  • Cliff Asness's Immunic position peaked at $244K in Q2 2018.
  • 24 funds tracked by Wall St. Rank held Immunic as of Q2 2019.

Based on AQR Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.